Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Submitted by
admin
on June 30, 2012 - 4:35pm
Source:
Pharmabiz
News Tags:
MLN9708
Multiple Myeloma
Millennium
Headline:
Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Do Not Allow Advertisers to Use My Personal information
